Order Article Reprints

Klinker KP, Hidayat LK, Wenzler E, Balada-Llasat J-M, Motyl M, DeRyke CA, Bauer KA. Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics. 2022; 11(5):660. https://doi.org/10.3390/antibiotics11050660

Klinker, Kenneth P., Levita K. Hidayat, Eric Wenzler, Joan-Miquel Balada-Llasat, Mary Motyl, C. Andrew DeRyke, and Karri A. Bauer. 2022. "Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States" Antibiotics 11, no. 5: 660. https://doi.org/10.3390/antibiotics11050660

Klinker, K. P., Hidayat, L. K., Wenzler, E., Balada-Llasat, J. -M., Motyl, M., DeRyke, C. A., & Bauer, K. A. (2022). Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics, 11(5), 660. https://doi.org/10.3390/antibiotics11050660